SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 455 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,938 | +52.0% | 19,704 | +77.0% | 0.01% | -16.7% |
Q2 2023 | $1,275 | -16.9% | 11,135 | 0.0% | 0.01% | -25.0% |
Q1 2023 | $1,535 | +6.4% | 11,135 | 0.0% | 0.01% | 0.0% |
Q4 2022 | $1,443 | -99.9% | 11,135 | 0.0% | 0.01% | +14.3% |
Q3 2022 | $1,231,000 | +47.4% | 11,135 | 0.0% | 0.01% | +40.0% |
Q2 2022 | $835,000 | -4.0% | 11,135 | 0.0% | 0.01% | +25.0% |
Q1 2022 | $870,000 | -13.3% | 11,135 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $1,003,000 | -2.6% | 11,135 | 0.0% | 0.00% | -20.0% |
Q3 2021 | $1,030,000 | +18.9% | 11,135 | 0.0% | 0.01% | +25.0% |
Q2 2021 | $866,000 | +4.3% | 11,135 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $830,000 | -56.3% | 11,135 | 0.0% | 0.00% | -55.6% |
Q4 2020 | $1,898,000 | +21.4% | 11,135 | 0.0% | 0.01% | +12.5% |
Q3 2020 | $1,564,000 | -12.4% | 11,135 | 0.0% | 0.01% | -20.0% |
Q2 2020 | $1,785,000 | +63.9% | 11,135 | 0.0% | 0.01% | +25.0% |
Q1 2020 | $1,089,000 | -20.0% | 11,135 | +5.6% | 0.01% | 0.0% |
Q4 2019 | $1,361,000 | +71.4% | 10,545 | 0.0% | 0.01% | +60.0% |
Q3 2019 | $794,000 | -50.4% | 10,545 | 0.0% | 0.01% | -50.0% |
Q2 2019 | $1,602,000 | +27.4% | 10,545 | 0.0% | 0.01% | +25.0% |
Q1 2019 | $1,257,000 | -11.2% | 10,545 | -18.7% | 0.01% | -20.0% |
Q4 2018 | $1,415,000 | -31.9% | 12,966 | +0.8% | 0.01% | -23.1% |
Q3 2018 | $2,077,000 | +22.4% | 12,861 | +0.2% | 0.01% | +18.2% |
Q2 2018 | $1,697,000 | +117.3% | 12,840 | +21.8% | 0.01% | +120.0% |
Q1 2018 | $781,000 | +33.0% | 10,545 | 0.0% | 0.01% | +25.0% |
Q4 2017 | $587,000 | +22.8% | 10,545 | 0.0% | 0.00% | +33.3% |
Q3 2017 | $478,000 | +34.6% | 10,545 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $355,000 | +13.8% | 10,545 | 0.0% | 0.00% | +50.0% |
Q1 2017 | $312,000 | +8.0% | 10,545 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $289,000 | -55.4% | 10,545 | 0.0% | 0.00% | -60.0% |
Q3 2016 | $648,000 | +175.7% | 10,545 | -14.5% | 0.01% | +150.0% |
Q2 2016 | $235,000 | -3.3% | 12,338 | -1.0% | 0.00% | 0.0% |
Q1 2016 | $243,000 | -46.5% | 12,462 | +5.9% | 0.00% | -50.0% |
Q4 2015 | $454,000 | +121.5% | 11,768 | +84.4% | 0.00% | +100.0% |
Q3 2015 | $205,000 | +5.7% | 6,383 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $194,000 | – | 6,383 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Avoro Capital Advisors LLC | 1,195,000 | $142,432,000 | 6.16% |
Casdin Capital, LLC | 305,000 | $36,353,000 | 3.99% |
Eventide Asset Management | 845,168 | $100,736,000 | 3.47% |
HIGHLINE CAPITAL MANAGEMENT, L.P. | 436,000 | $51,967,000 | 3.26% |
NEXTHERA CAPITAL LP | 21,270 | $2,535,000 | 3.08% |
Camber Capital Management LP | 500,000 | $59,595,000 | 2.97% |
Eversept Partners, LP | 83,574 | $9,961,185 | 2.91% |
CADIAN CAPITAL MANAGEMENT, LP | 610,546 | $72,771,000 | 2.84% |
RTW INVESTMENTS, LP | 338,199 | $40,310,000 | 2.75% |
Cormorant Asset Management, LP | 300,000 | $35,757,000 | 2.42% |